The response to DP was tumor antigen–specific, as the number of OVA-specific CD8+ tumor-infiltrated lymphocytes (TILs) was augmented identified by H2-Kb OVA257-264 tetramer staining (Figure 4F and Supplemental Figure 6F). This evidence concerns the gene CD8A and neoplasm.